SNN vs. GEHC, PHG, ZBH, SOLV, PEN, STVN, GKOS, NARI, INSP, and IRTC
Should you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry.
Smith & Nephew vs.
Smith & Nephew (NYSE:SNN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, community ranking, risk and valuation.
Smith & Nephew has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.
25.6% of Smith & Nephew shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 1.0% of Smith & Nephew shares are held by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Smith & Nephew pays an annual dividend of $0.89 per share and has a dividend yield of 3.1%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew pays out 41.2% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years.
GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.
In the previous week, GE HealthCare Technologies had 13 more articles in the media than Smith & Nephew. MarketBeat recorded 21 mentions for GE HealthCare Technologies and 8 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 1.71 beat GE HealthCare Technologies' score of 1.52 indicating that Smith & Nephew is being referred to more favorably in the media.
Smith & Nephew currently has a consensus target price of $28.00, suggesting a potential downside of 3.28%. GE HealthCare Technologies has a consensus target price of $88.27, suggesting a potential upside of 25.58%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew.
Smith & Nephew received 418 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. However, 62.00% of users gave GE HealthCare Technologies an outperform vote while only 54.10% of users gave Smith & Nephew an outperform vote.
GE HealthCare Technologies has a net margin of 10.13% compared to Smith & Nephew's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.74% beat Smith & Nephew's return on equity.
Summary
GE HealthCare Technologies beats Smith & Nephew on 17 of the 22 factors compared between the two stocks.
Get Smith & Nephew News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Smith & Nephew Competitors List
Related Companies and Tools
This page (NYSE:SNN) was last updated on 5/21/2025 by MarketBeat.com Staff
Buy SNN Stock Free SNN Stock Alerts